Phase 1, Open Label, Dose Escalation Study to Evaluate the Safety, Expansion, Persistence, and Preliminary Clinical Activity of Autologous CD64 CAR T Cells in Patients With Relapsed and/or Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (HR-MDS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07347418

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:37.525915+00:00

Published At

2026-01-16T00:00:00+00:00

Record Updated At

2026-01-16

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Refractory Acute Myeloid Leukemia (AML)", "High-risk Myelodysplastic Syndrome (MDS)", "Relapsed Acute Myeloid Leukemia (AML)", "Myelodysplastic Syndrome (MDS)/AML", "Myelodysplastic Syndrome", "AML (Acute Myeloid Leukemia)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-01-16"

protocolSection.identificationModule.nctId

"NCT07347418"

protocolSection.identificationModule.officialTitle

"Phase 1, Open Label, Dose Escalation Study to Evaluate the Safety, Expansion, Persistence, and Preliminary Clinical Activity of Autologous CD64 CAR T Cells in Patients With Relapsed and/or Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (HR-MDS)"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Refractory Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
• High-risk Myelodysplastic Syndrome (MDS) (protocolSection.conditionsModule.conditions)
• Relapsed Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
• Myelodysplastic Syndrome (MDS)/AML (protocolSection.conditionsModule.conditions)
• Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• AML (Acute Myeloid Leukemia) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.